Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole augmentation in antidepressant non-responders with major depressive disorder
2006-004605-26Phase 4Terminated
- Sponsor
- Manchester Mental Health and Social Care NHS Trust
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of aripiprazole in major depressive disorder (MDD) and treatment-resistant depression (TRD), sponsored by Manchester Mental Health and Social Care NHS Trust. Primary endpoint: Remission by HAM-D17. Started Jan 2007; status: terminated.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)treatment-resistant depression (TRD)
Beyond the preview
Go deeper on 2006-004605-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004605-26.